PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 17, 2026Journal of the American College of Cardiology293 citationsOpen Access

Predictors of Outcomes After Reperfusion for Acute Myocardial Infarction

Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: The primary angioplasty in myocardial infarction (PAMI) trial

View Full Paper
Ask AI
Bookmark
Share

Why the study?

The optimal reperfusion strategy for acute myocardial infarction remained controversial, and predictors of outcome in the reperfusion era had been incompletely characterized.

Does primary angioplasty reduce mortality and reinfarction compared to t-PA in patients with acute transmural myocardial infarction?

Population

395 patients presenting within 12 h of onset of acute transmural myocardial infarction at 12 centers

Comparison

Primary angioplasty without antecedent thrombolysis vs t-PA

Design

Prospective randomized trial

Follow-up

6-month

Key result

Primary angioplasty significantly reduced in-hospital mortality compared to t-PA (2.6% vs. 6.5%, p=0.039) in patients with acute transmural myocardial infarction.

Authors

GSGregg W. StoneCGCindy L. GrinesKBKevin F. Browne

Discussion

Loading...

Member takes

Key expert perspectives

Captured external expert commentary on this paper, strongest first. Original sources linked on every quote.

DWDouglas WeaverProfessor of medicine, University of Washington

“It's not time for all of us to change our practice.”

University of WashingtonNews Coverage
WOWilliam O'NeillDirector of cardiovascular disease, Beaumont Hospital

“Two years ago in a head-to-head comparison [in PAMI-1] we found that mortality with tPA was 6.5 percent and with angioplasty it was 2.5 percent.”

William Beaumont HospitalNews Coverage

Overview

Primary angioplasty is superior to thrombolytic therapy with t-PA in reducing in-hospital mortality, reinfarction, and recurrent ischemia in patients with acute myocardial infarction, with benefits maintained at 6 months.

Key Points

  • Identify independent clinical predictors of in-hospital and 6-month outcomes in patients receiving primary angioplasty versus tissue-type plasminogen activator thrombolysis for acute myocardial infarction.
  • Randomized trial conducted across 12 centers enrolling 395 patients presenting within 12 hours of acute transmural myocardial infarction.
  • Patients were randomized to receive tissue-type plasminogen activator (t-PA) or undergo primary angioplasty without antecedent thrombolysis.
  • Sixteen clinical variables were assessed using univariate and multiple logistic regression analyses to determine predictors of outcome.
  • Advanced age and treatment assignment were the only independent predictors of in-hospital mortality, with lower mortality in the angioplasty arm compared to t-PA (2.6% vs. 6.5%, p = 0.039).
  • In-hospital death or nonfatal reinfarction was significantly reduced with angioplasty versus t-PA (5.1% vs. 12.0%, p = 0.02), with pronounced benefit in patients ≥65 years (8.6% vs. 20.0%, p = 0.048).
  • Primary angioplasty significantly reduced recurrent ischemic events compared to t-PA (10.3% vs. 28.0%, p = 0.0001) and maintained lower death or reinfarction rates at 6 months (8.2% vs. 17.0%, p = 0.02).

Study Design

Type

RCT (n=395)

Multicenter

Yes

Structured PICO

Does primary angioplasty reduce mortality and reinfarction compared to t-PA in patients with acute transmural myocardial infarction?

P
Population
395 patients presenting within 12 hours of onset of acute transmural myocardial infarction, randomized to primary angioplasty or t-PA, followed for 6 months.
I
Intervention
Primary angioplasty without antecedent thrombolysis
C
Comparator
Tissue-type plasminogen activator (t-PA)
O
Outcome
In-hospital mortality and composite of in-hospital death or nonfatal reinfarctionhard clinical

Primary angioplasty is superior to thrombolytic therapy with t-PA in reducing in-hospital mortality, reinfarction, and recurrent ischemia in patients with acute myocardial infarction, with benefits maintained at 6 months.

Main Result

Absolute Event Rate: 2.6% vs 6.5%

p-value: p=0.039

Cite This Study

Stone et al. (1995) conducted an RCT in Acute transmural myocardial infarction (n=395). Primary angioplasty vs. Tissue-type plasminogen activator (t-PA) was evaluated on In-hospital mortality (p=0.039). Primary angioplasty significantly reduced in-hospital mortality compared to t-PA (2.6% vs. 6.5%, p=0.039) in patients with acute transmural myocardial infarction.

synapsesocial.com/papers/6a83267cbd1fa53dac838280https://doi.org/10.1016/0735-1097(94)00367-y
View Full Paper
Ask AI
Bookmark
Share